# Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients

> **NCT00762892** · PHASE4 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 33 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** Raltegravir and truvada
- **DRUG:** Atazanavir, Norvir and Truvada

## Key facts

- **NCT ID:** NCT00762892
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-01
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2015-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762892, "Raltegravir vs. Atazanavir in Combination With Truvada® for the Treatment of Antiretroviral naïve HIV Infected Patients". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00762892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*